Jasper Therapeutics, Inc. SEC filings JSPR
Jasper Therapeutics, Inc. has 483 filings in SEC EDGAR's recent list, going back to Sep 13, 2019. Its latest annual report, Form ARS, was filed on Jun 15, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (change to shareholder rights, bylaw or fiscal year change, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
|
Nov 4, 2026 | Nov 2, 2026 |
| SC TO-I/A | Amendment no. 1 to form sc to-i | Oct 23, 2026 | — |
| DEF 14A | Proxy statement | Oct 19, 2026 | Nov 13, 2026 |
| 8-K |
Current report
Other events
|
Oct 15, 2026 | Oct 15, 2026 |
| S-3 | Shelf registration | Oct 14, 2026 | — |
| PRE 14A | Preliminary proxy statement | Oct 9, 2026 | Oct 9, 2026 |
| 8-K |
Current report
Other events
|
Oct 7, 2026 | Oct 7, 2026 |
| SC TO-I | Form sc to-i | Oct 7, 2026 | — |
| 8-K |
Current report
Shareholder vote results
|
Oct 5, 2026 | Sep 30, 2026 |
| 8-K/A | Amended current report | Oct 5, 2026 | Jul 16, 2026 |
| 8-K/A | Amended current report | Oct 1, 2026 | Jul 16, 2026 |
| 8-K |
Current report
Officer or director change
|
Sep 28, 2026 | Sep 23, 2026 |
| 25-NSE | Delisting notice | Sep 24, 2026 | — |
| DEF 14A | Proxy statement | Sep 4, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Material agreement
|
Aug 26, 2026 | Aug 21, 2026 |
| PRE 14A | Preliminary proxy statement | Aug 24, 2026 | Aug 24, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 14, 2026 | Aug 14, 2026 |
| 10-Q | Quarterly report | Aug 14, 2026 | Jun 30, 2026 |
| D | Filing | Aug 5, 2026 | — |
| 8-K |
Current report
Shareholder vote results
|
Aug 3, 2026 | Jul 31, 2026 |
| 8-K |
Current report
Other events
|
Jul 31, 2026 | Jul 31, 2026 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure
|
Jul 17, 2026 | Jul 16, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 16, 2026 | Jul 16, 2026 |
| ARS | Annual report to shareholders | Jun 15, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Jun 15, 2026 | — |
| DEF 14A | Proxy statement | Jun 15, 2026 | Jul 31, 2026 |
| 8-K |
Current report
Listing notice
|
Jun 9, 2026 | Jun 3, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 1, 2026 | Jun 1, 2026 |
| 8-K |
Current report
Officer or director change
|
May 21, 2026 | May 15, 2026 |
| 10-Q | Quarterly report | May 14, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 14, 2026 | May 14, 2026 |
| 10-K/A | Amended annual report | Apr 30, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 30, 2026 | Mar 30, 2026 |
| 10-K | Annual report | Mar 30, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Other events
|
Jan 8, 2026 | Jan 8, 2026 |
| 8-K |
Current report
Officer or director change, Other events
|
Jan 7, 2026 | Jan 2, 2026 |
| 8-K |
Current report
Other events
|
Dec 2, 2025 | Dec 2, 2025 |
| 10-Q | Quarterly report | Nov 10, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2025 | Nov 10, 2025 |
| 8-K |
Current report
Material agreement, Other events
|
Sep 19, 2025 | Sep 18, 2025 |
| 424B5 | Prospectus supplement | Sep 19, 2025 | — |
| 424B5 | Prospectus supplement | Sep 18, 2025 | — |
| 8-K |
Current report
Results of operations
|
Aug 13, 2025 | Aug 13, 2025 |
| 10-Q | Quarterly report | Aug 13, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Exit or restructuring costs, Officer or director change, Other events
|
Jul 9, 2025 | Jul 8, 2025 |
| 8-K |
Current report
Other events
|
Jul 7, 2025 | Jul 7, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jul 3, 2025 | Jul 3, 2025 |
| 8-K |
Current report
Other events
|
Jun 16, 2025 | Jun 14, 2025 |
| ARS | Annual report to shareholders | May 19, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | May 19, 2025 | — |
| DEF 14A | Proxy statement | May 19, 2025 | Jul 3, 2025 |
| 8-K |
Current report
Results of operations
|
May 12, 2025 | May 12, 2025 |
| 10-Q | Quarterly report | May 12, 2025 | Mar 31, 2025 |
| EFFECT | Filing | Mar 26, 2025 | — |
| 424B5 | Prospectus supplement | Mar 26, 2025 | — |
| CORRESP | Letter to the SEC | Mar 24, 2025 | — |
| UPLOAD | Letter from the SEC | Mar 21, 2025 | — |
| 8-K |
Current report
Material agreement, Agreement ended
|
Mar 19, 2025 | Mar 14, 2025 |
| S-3 | Shelf registration | Mar 19, 2025 | — |
| 10-K | Annual report | Feb 28, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Feb 27, 2025 | Feb 27, 2025 |
| 8-K |
Current report
Other events
|
Jan 8, 2025 | Jan 8, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2024 | Nov 7, 2024 |
| 10-Q | Quarterly report | Nov 7, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Other events
|
Oct 15, 2024 | Oct 14, 2024 |
| 10-Q | Quarterly report | Aug 13, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Officer or director change, Other events
|
Jun 20, 2024 | Jun 17, 2024 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 12, 2024 | Jun 6, 2024 |
| S-8 POS | Post effective amendment no. 1 to form s-8 | Jun 7, 2024 | — |
| S-8 POS | Post effective amendment no. 1 to form s-8 | Jun 7, 2024 | — |
| S-8 POS | Post effective amendment no. 1 to form s-8 | Jun 7, 2024 | — |
| S-8 | Employee stock plan registration | Jun 7, 2024 | — |
| 10-Q | Quarterly report | May 14, 2024 | Mar 31, 2024 |
| DEFA14A | Additional proxy material | May 3, 2024 | — |
| ARS | Annual report to shareholders | Apr 22, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 22, 2024 | — |
| DEF 14A | Proxy statement | Apr 22, 2024 | Jun 6, 2024 |
| S-8 | Employee stock plan registration | Mar 5, 2024 | — |
| 10-K | Annual report | Mar 5, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 4, 2024 | Mar 4, 2024 |
| 424B5 | Prospectus supplement | Feb 7, 2024 | — |
| 8-K |
Current report
Material agreement, Other events
|
Feb 6, 2024 | Feb 6, 2024 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change
|
Jan 4, 2024 | Jan 3, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 2, 2024 | Jan 2, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Dec 20, 2023 | Dec 15, 2023 |
| DEF 14A | Proxy statement | Nov 20, 2023 | Dec 15, 2023 |
| PRE 14A | Preliminary proxy statement | Nov 9, 2023 | Nov 9, 2023 |
| 10-Q | Quarterly report | Nov 9, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 9, 2023 | Nov 9, 2023 |
| 8-K |
Current report
Officer or director change, Other events
|
Nov 1, 2023 | Oct 30, 2023 |
| 8-K |
Current report
Listing notice
|
Oct 20, 2023 | Oct 18, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 10, 2023 | Oct 10, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 10, 2023 | Oct 9, 2023 |
| 8-K |
Current report
Officer or director change, Other events
|
Sep 25, 2023 | Sep 21, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 21, 2023 | Sep 21, 2023 |
| S-8 | Employee stock plan registration | Aug 11, 2023 | — |
| 10-Q | Quarterly report | Aug 11, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2023 | Aug 11, 2023 |
| 8-K |
Current report
Officer or director change, Other events
|
Jun 20, 2023 | Jun 20, 2023 |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results
|
Jun 8, 2023 | Jun 2, 2023 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 2, 2023 | Jun 2, 2023 |
| 10-Q | Quarterly report | May 12, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations
|
May 12, 2023 | May 12, 2023 |
| EFFECT | Filing | May 5, 2023 | — |
| 424B5 | Prospectus supplement | May 5, 2023 | — |
| CORRESP | Letter to the SEC | May 3, 2023 | — |
| UPLOAD | Letter from the SEC | May 2, 2023 | — |
| S-3 | Shelf registration | Apr 28, 2023 | — |
| ARS | Annual report to shareholders | Apr 21, 2023 | Dec 31, 2022 |
| DEFA14A | Additional proxy material | Apr 21, 2023 | — |
| DEF 14A | Proxy statement | Apr 21, 2023 | Jun 7, 2023 |
| 8-K |
Current report
Material agreement, Officer or director change
|
Apr 14, 2023 | Apr 13, 2023 |
| PRE 14A | Preliminary proxy statement | Apr 10, 2023 | Apr 10, 2023 |
| S-8 | Employee stock plan registration | Mar 8, 2023 | — |
| 10-K | Annual report | Mar 8, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 8, 2023 | Mar 8, 2023 |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure, Other events
|
Feb 17, 2023 | Feb 16, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 16, 2023 | Feb 16, 2023 |
| 8-K |
Current report
Other events
|
Jan 27, 2023 | Jan 27, 2023 |
| 8-K |
Current report
Material agreement, Other events
|
Jan 25, 2023 | Jan 25, 2023 |
| 424B5 | Prospectus supplement | Jan 25, 2023 | — |
| 424B5 | Prospectus supplement | Jan 24, 2023 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 24, 2023 | Jan 24, 2023 |
| 8-K |
Current report
Other events
|
Jan 19, 2023 | Jan 18, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 13, 2023 | Jan 13, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 10, 2023 | Jan 10, 2023 |
| 8-K |
Current report
Other events
|
Nov 10, 2022 | Nov 10, 2022 |
| 424B5 | Prospectus supplement | Nov 10, 2022 | — |
| 10-Q | Quarterly report | Nov 10, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2022 | Nov 10, 2022 |
| 8-K |
Current report
Listing notice
|
Nov 4, 2022 | Nov 3, 2022 |
| EFFECT | Filing | Oct 18, 2022 | — |
| 424B3 | Prospectus | Oct 18, 2022 | — |
| CORRESP | Letter to the SEC | Oct 14, 2022 | — |
| EFFECT | Filing | Oct 13, 2022 | — |
| UPLOAD | Letter from the SEC | Oct 13, 2022 | — |
| POS AM | Post-effective amendment no. 2 to form s-1 | Oct 7, 2022 | — |
| S-3 | Shelf registration | Oct 7, 2022 | — |
| 424B3 | Prospectus | Aug 12, 2022 | — |
| 10-Q | Quarterly report | Aug 12, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2022 | Aug 12, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 27, 2022 | Jun 23, 2022 |
| 424B3 | Prospectus | May 12, 2022 | — |
| 10-Q | Quarterly report | May 12, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Results of operations
|
May 12, 2022 | May 12, 2022 |
| DEFA14A | Additional proxy material | Apr 29, 2022 | — |
| DEF 14A | Proxy statement | Apr 29, 2022 | Jun 23, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 27, 2022 | Apr 27, 2022 |
| 424B3 | Prospectus | Apr 1, 2022 | — |
| EFFECT | Filing | Mar 29, 2022 | — |
| POS AM | Post effective registration statement | Mar 24, 2022 | — |
| S-8 | Employee stock plan registration | Mar 22, 2022 | — |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Mar 21, 2022 | Mar 17, 2022 |
| S-8 | Employee stock plan registration | Mar 18, 2022 | — |
| 10-K | Annual report | Mar 18, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Results of operations
|
Mar 18, 2022 | Mar 18, 2022 |
| 8-K |
Current report
Officer or director change
|
Mar 16, 2022 | Mar 14, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 16, 2022 | Mar 16, 2022 |
| 8-K |
Current report
Officer or director change
|
Mar 11, 2022 | Mar 7, 2022 |
| 8-K |
Current report
Officer or director change, Other events
|
Feb 28, 2022 | Feb 25, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 25, 2022 | Feb 24, 2022 |
| 424B3 | Prospectus | Nov 12, 2021 | — |
| 10-Q | Quarterly report | Nov 12, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2021 | Nov 12, 2021 |
| 424B3 | Prospectus | Oct 29, 2021 | — |
| 8-K |
Current report
Officer or director change
|
Oct 29, 2021 | Oct 25, 2021 |
| EFFECT | Filing | Oct 26, 2021 | — |
| 424B3 | Prospectus | Oct 26, 2021 | — |
| CORRESP | Letter to the SEC | Oct 22, 2021 | — |
| UPLOAD | Letter from the SEC | Oct 22, 2021 | — |
| S-1 | Registration statement | Oct 18, 2021 | — |
| 8-K/A |
Amended current report
Change to shareholder rights, Bylaw or fiscal year change
|
Sep 29, 2021 | Sep 24, 2021 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Auditor change, Change in control, Officer or director change, Regulation FD disclosure
|
Sep 29, 2021 | Sep 24, 2021 |
| 25-NSE | Delisting notice | Sep 27, 2021 | — |
| 8-K |
Current report
Shareholder vote results, Other events
|
Sep 23, 2021 | Sep 22, 2021 |
| 425 | Current report | Sep 20, 2021 | — |
| 8-K |
Current report
Other events
|
Sep 20, 2021 | Sep 20, 2021 |
| 425 | Current report | Sep 9, 2021 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 9, 2021 | Sep 9, 2021 |
| 425 | Form 425 | Sep 8, 2021 | — |
| SEC STAFF LETTER | Filing | Aug 27, 2021 | — |
| EFFECT | Filing | Aug 26, 2021 | — |
| 424B3 | Prospectus | Aug 26, 2021 | — |
| S-4/A | Registration statement | Aug 25, 2021 | — |
| CORRESP | Letter to the SEC | Aug 24, 2021 | — |
| SEC STAFF LETTER | Filing | Aug 24, 2021 | — |
| CORRESP | Letter to the SEC | Aug 20, 2021 | — |
| S-4/A | Registration statement | Aug 20, 2021 | — |
| UPLOAD | Letter from the SEC | Aug 17, 2021 | — |
| 10-Q | Quarterly report | Aug 16, 2021 | Jun 30, 2021 |
| S-4/A | Registration statement | Aug 9, 2021 | — |
| CORRESP | Letter to the SEC | Aug 6, 2021 | — |
| UPLOAD | Letter from the SEC | Aug 5, 2021 | — |
| UPLOAD | Letter from the SEC | Aug 3, 2021 | — |
| 10-Q/A | Amended quarterly report | Jul 23, 2021 | Mar 31, 2021 |
| CORRESP | Letter to the SEC | Jul 22, 2021 | — |
| UPLOAD | Letter from the SEC | Jul 22, 2021 | — |
| CORRESP | Letter to the SEC | Jul 21, 2021 | — |
| S-4/A | Registration statement | Jul 19, 2021 | — |
| 10-Q/A | Amended quarterly report | Jul 19, 2021 | Mar 31, 2021 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- JSPR (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Redwood City, CA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1788028
- Former names
- Amplitude Healthcare Acquisition Corp (until Sep 29, 2021)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.